Women More Likely to Be Told Autoimmune Conditions Are Psychological 2026

Women with autoimmune conditions are significantly more likely to be told their symptoms are psychological or stress-induced, according to a new study from Cambridge University and the University of East Anglia. The research reveals a stark gender divide in how autoimmune diseases are diagnosed, with women facing both psychiatric and psychosomatic misdiagnosis at far higher rates than men.

What the Study Found

The study examined diagnostic patterns for autoimmune conditions—diseases where the immune system mistakenly attacks the body. Researchers found that women are 43% more likely than men to receive a psychiatric misdiagnosis, meaning an autoimmune issue is incorrectly labeled as a mental health problem.

Even more striking, women are 74% more likely to receive a psychosomatic misdiagnosis, where symptoms are dismissed as psychological or stress-induced rather than recognized as physical. This gap persists even when symptoms are identical across genders.

Women also reported significantly longer delays between symptom onset and diagnosis—one to two years compared to less than three months for men. This delay can have serious consequences for disease management and long-term health outcomes.

Why Are Women More Likely to Be Misdiagnosed?

The reasons behind this disparity are complex and likely stem from a combination of medical bias, historical stereotypes, and differences in symptom presentation. Autoimmune conditions themselves are more common in women—roughly 78% of those affected are female—which may paradoxically make doctors less likely to consider them.

Additionally, many autoimmune symptoms, such as fatigue, pain, and brain fog, overlap with those of anxiety and depression. When doctors anchor on a mental health explanation, they may stop looking for underlying physical causes.

Studies have shown that women's pain is often taken less seriously than men's, and women are more likely to be prescribed sedatives or antidepressants for symptoms that later turn out to have a physical basis.

The Real-World Impact of Misdiagnosis

Misdiagnosis is not just a matter of delayed treatment—it can lead to unnecessary suffering, harmful treatments, and loss of trust in the healthcare system. Women who are told their symptoms are "all in their head" may hesitate to seek further care or may be reluctant to report new symptoms.

The study's authors emphasize that delays in diagnosis can allow autoimmune diseases to progress, potentially causing irreversible damage. For conditions like lupus, rheumatoid arthritis, or multiple sclerosis, early intervention is critical. The background to this story is set out in Black Women Fly to South Korea for Affordable Healthcare. A related thread runs through Black Women Fly to South Korea for Healthcare: A Medical Tourism. Earlier coverage in Sweden Ends Liberia Aid: Women's Rights and Health at Risk shows how the argument developed.

What Can Be Done?

Raising awareness among both patients and healthcare providers is a crucial first step. Women should feel empowered to seek a second opinion if they feel their symptoms are being dismissed. Keeping a detailed symptom diary and requesting specific tests can also help. A closer look at the same subject appears in Strait of Hormuz Closure: Iran's Conditions for Reopening. Anyone following the wider picture can start with Poorest Children 40% More Likely Hospitalized for Lung. The same theme surfaces in Poorest Children 40% More Likely Hospitalized for Lung Infections, which takes a different angle.

Medical training programs are increasingly incorporating awareness of implicit bias, but change is slow. The study's findings underscore the need for systemic reforms in how autoimmune conditions are diagnosed, particularly for women. Context on how this played out before sits in Christina Applegate Reveals Multiple Sclerosis Misdiagnosis.

Key Takeaways

• Women are 43% more likely than men to receive a psychiatric misdiagnosis for autoimmune conditions.
• Women are 74% more likely to receive a psychosomatic misdiagnosis, where symptoms are attributed to stress or mental health.
• Diagnostic delays for women average one to two years, compared to less than three months for men.
• Autoimmune conditions affect women disproportionately, yet diagnostic bias persists.
• Self-advocacy, second opinions, and symptom tracking can help counter misdiagnosis.

Comparison of Diagnostic Experiences by Gender

The study's findings highlight a troubling pattern that many women with autoimmune conditions know all too well: being told their symptoms are psychological when they are, in fact, physical. This experience is so common that it has become a rallying cry for better awareness and research. As we continue to understand the gender disparities in healthcare, it's essential to listen to women's experiences and push for change. For a deeper look at how women's health concerns are often dismissed, see our article on women more likely to be told autoimmune conditions are psychological.

If you or a loved one has faced similar challenges, know that you are not alone. Sharing stories and demanding better from the healthcare system can drive progress. The path to diagnosis may be long, but with persistence and support, women can find answers and appropriate care.